Skip to main content
SpringerLink
Log in
Book cover

Sexually Transmitted Infections pp 255–275Cite as

Sexually Transmitted Hepatitis

  • Chapter
  • First Online:

  • 796 Accesses

Abstract

Viral hepatitis infections occur worldwide, although the specific epidemiology changes according to the geographic region and the route of transmission. Nevertheless, sexual spread may be accounted for a relevant number of cases. Hepatitis B virus is a well-recognized sexually transmitted infection in both developed and developing countries. Hepatitis A virus (HAV) is generally considered transmitted via the fecal-oral route or through contaminated food or water. Nevertheless, person-to-person contact has been suggested in the men who have sex with men (MSM) community since the end of the 1970s. During the following decades, several outbreaks have defined epidemiology and risk factors for HAV acquisition through sexual contact in this population. Similarly, sexual transmission for hepatitis C (HCV) infection was not considered efficient until the occurrence of outbreaks in the MSM community following specific sexual practices such as fisting, chemsex/slamsex, and other traumatic procedures that might lead to permucosal, sexual transmission of HCV.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Thomas D, Zoulim F. New challenges in viral hepatitis. Gut. 2012;61:i1–5.

    Article  PubMed  CAS  Google Scholar 

  2. Havelaar AH, Kirk MD, Torgerson PR, et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. 2015;12:e1001923.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Burroughs AK, Westaby D. Chapter 7 - liver, biliary tract and pancreatic disease. In: Kumar P, Clark M, editors. Clinical medicine. London: Elsevier Saunders; 2005. p. 362–4.

    Google Scholar 

  4. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of virus like antigen associated with acute illness. Science. 1973;182:1026–8.

    Article  PubMed  CAS  Google Scholar 

  5. Gorgos L. Sexual transmission of viral hepatitis. Infectious Disease Clinics of North America. 2013;27:811–36.

    Article  PubMed  Google Scholar 

  6. Freidl GS, Sonder GJB, Bovée LPMJ, et al. Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Euro Surveill. 2017;22:30468.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mayer KH, Maloney KM, Levine K, et al. Sociodemographic and clinical factors associated with increasing bacterial sexually transmitted infection diagnoses in men who have sex with men accessing care at a Boston Community Health Center (2005-2015). Open Forum Infect Dis. 2017;4:ofx214.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48:1–37.

    Google Scholar 

  9. Centers for Disease Control and Prevention. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis – United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;54:1–33.

    Google Scholar 

  10. Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130:1129–34.

    Article  PubMed  Google Scholar 

  11. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int. 2010;30:5–18.

    Article  PubMed  CAS  Google Scholar 

  12. European Centre for Disease Prevention and Control. Technical Report. Hepatitis A virus in the EU/EEA, 1975-2014. A systematic review of seroprevalence and incidence comprising European surveillance data and national vaccination recommendations. Available at https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/hepatitis-a-virus-EU-EEA-1975-2014.pdf. Accessed 03 February 2018.

  13. Weerakoon AP, Chena MY, Read TRH, Bradshaw C, Fairley CK. Immunity to hepatitis A when outbreaks of infection in men who have sex with men (MSM) are rare. Vaccine. 2012;30:3430–4.

    Article  PubMed  Google Scholar 

  14. Zucman D, Farfour E, Mazaux L. How to face the outbreak of viral Hepatitis A in men who have sex with men in France without vaccines? Clin Infect Dis. 2017;65:1051–3.

    Article  Google Scholar 

  15. Regan DG, Wood JG, Benevent C, et al. Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men. Epidemiol Infect. 2016;144:1528–37.

    Article  PubMed  CAS  Google Scholar 

  16. Chen G, Lin K, Sun H, et al. Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: impact of HAV vaccination. Liver Int. 2017;38(4):594–601. https://doi.org/10.1111/liv.13468.

    Article  PubMed  Google Scholar 

  17. Stuurman AL, Marano C, Bunge EM, De Moerlooze L, Shouval D. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – a systematic review. Hum Vaccin Immunother. 2017;13:724–36.

    Article  PubMed  Google Scholar 

  18. Stokes J, Neefe JR. The prevention and attenuation of infectious hepatitis by gamma globulin. JAMA. 1945;127:144–5.

    Article  Google Scholar 

  19. Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine. 1997;15:1157–61.

    Article  PubMed  CAS  Google Scholar 

  20. Parrón I, Planas C, Godoy P, et al. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Hum Vaccin Immunother. 2017;13:423–7.

    Article  PubMed  Google Scholar 

  21. Hepatitis E: epidemiology and disease burden. Available at http://www.who.int/immunization/sage/meetings/2014/october/1_HEV_burden_paper_final_03_Oct_14_yellow_book.pdf?ua=1,&ua=1. Accessed 03 February 2018.

  22. Lewis HC, Boisson S, Ijaz S, et al. Hepatitis E in England and Wales. Emerg Infect Dis. 2008;14:165–7.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Amon JJ, Drobeniuc J, Bower WA, et al. Locally acquired hepatitis E virus infection, El Paso, Texas. J Med Virol. 2006;78:741–6.

    Article  PubMed  Google Scholar 

  24. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20:23–31.

    Article  PubMed  CAS  Google Scholar 

  25. Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.

    Article  PubMed  Google Scholar 

  26. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494–503.

    Article  PubMed  CAS  Google Scholar 

  27. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369:1260.

    Article  PubMed  CAS  Google Scholar 

  28. Lanini S, Garbuglia AR, Lapa D, et al. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy. BMJ Open. 2015;5:e007110.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Payne BA, Medhi M, Ijaz S, et al. Hepatitis E virus seroprevalence among men who have sex with men, United Kingdom. Emerg Infect Dis. 2013;19:333–5.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Dauby N, Suin V, Jacques M, et al. Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, Belgium. Epidemiol Infect. 2017;145:3370–4.

    Article  PubMed  CAS  Google Scholar 

  31. Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481–9.

    Article  PubMed  Google Scholar 

  33. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–7.

    Article  PubMed  CAS  Google Scholar 

  34. Kamar N, Abravanel F, Garrouste C, et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant. 2010;25:2792–5.

    Article  PubMed  CAS  Google Scholar 

  35. Jagjit Singh GK, Ijaz S, Rockwood N, et al. Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect. 2013;66:103–6.

    Article  PubMed  Google Scholar 

  36. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139:1612–8.

    Article  PubMed  CAS  Google Scholar 

  37. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376:895–902.

    Article  PubMed  CAS  Google Scholar 

  38. Zhang J, Shih JW, Xia NS. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:914–22.

    Article  PubMed  CAS  Google Scholar 

  39. Su YY, Huang SJ, Guo M, et al. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination. Clin Microbiol Infect. 2012;23:336.e1–4.

    Article  CAS  Google Scholar 

  40. Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med. 2005;118:1413.

    Article  PubMed  Google Scholar 

  41. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.

    Article  PubMed  CAS  Google Scholar 

  42. Ozer A, Khaoustov VI, Mearns M, et al. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology. 1996;110:1519–28.

    Article  PubMed  CAS  Google Scholar 

  43. Huang HC, Chen CC, Chang WC, et al. Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis. J Virol. 2012;86:9443–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Newbold JE, Xin H, Tencza M, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol. 1995;69:3350–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Gómez-Moreno A, Garaigorta U. Hepatitis B virus and DNA damage response: interactions and consequences for infection. Viruses. 2017;9:304.

    Article  PubMed Central  CAS  Google Scholar 

  46. Staprans S, Loeb DD, Ganem D. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol. 1991;65:1255–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci USA. 2007;104:10205–10.

    Article  PubMed  CAS  Google Scholar 

  48. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010;40:14–30.

    Article  PubMed  Google Scholar 

  49. Olinger CM, Jutavijittum P, Hübschen JM, et al. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis. 2008;14:1777–80.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype. J Virol. 2009;83:10538–47.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. World Health Organization. Hepatitis B. Available from http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed 15 February 2018.

  52. Maynard JE. Hepatitis B: global importance and need for control. Vaccine. 1990;8:S18–20.

    Article  PubMed  Google Scholar 

  53. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and Southeast Asia. Gut. 1996;38:S18–23.

    Article  PubMed  PubMed Central  Google Scholar 

  54. European Center for Disease Control and Prevention. Hepatitis B – annual epidemiological report for 2015. Available at https://ecdc.europa.eu/en/publications-data/hepatitis-b-annual-epidemiological-report-2015-0. Accessed 18 February 2018.

  55. Wasley A, Miller JT, Finelli L. Surveillance for acute viral hepatitis—United States, 2005. MMWR Surveill Summ. 2007;56:1–24.

    PubMed  Google Scholar 

  56. Ayoola EA, Odelola HA, Ladipo OA. Hepatitis B surface antigen in menstrual blood and semen. Int J Gynaecol Obstet. 1980;18:185–7.

    Article  PubMed  CAS  Google Scholar 

  57. Karayiannis P, Novick DM, Lok AS, et al. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J. 1985;290:1853–5.

    Article  CAS  Google Scholar 

  58. Men BY, Xu HW, Wang XL. Hepatitis B surface antigen (HBsAg) in feces of convalescent hepatitis B patients. Chin Med J. 1989;102:596–9.

    PubMed  CAS  Google Scholar 

  59. Reiner NE, Judson FN, Bond WW, et al. Asymptomatic rectal mucosal lesions and hepatitis B surface antigen at sites of sexual contact in homosexual men with persistent hepatitis B virus infection. Ann Intern Med. 1982;96:170–3.

    Article  PubMed  CAS  Google Scholar 

  60. Scott RM, Snitbhan R, Bancroft WH, et al. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis. 1980;142:67–71.

    Article  PubMed  CAS  Google Scholar 

  61. Berry WR, Gottesfeld RL, Alter HJ, et al. Transmission of hepatitis B virus by artificial insemination. JAMA. 1987;257:1079–81.

    Article  PubMed  CAS  Google Scholar 

  62. Hess G, Bienzle U, Slusarczyk J, et al. Hepatitis B virus and delta infection in male homosexuals. Liver. 1986;6:13–6.

    Article  PubMed  CAS  Google Scholar 

  63. Kingsley LA, Rinaldo CR Jr, Lyter DW, et al. Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA. 1990;264:230–4.

    Article  PubMed  CAS  Google Scholar 

  64. Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis. 1991;11:73–83.

    Article  PubMed  CAS  Google Scholar 

  65. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 2003;43:788–98.

    Article  PubMed  Google Scholar 

  66. Kao JH, Chen PJ, Lai MY, et al. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology. 2001;34:817–23.

    Article  PubMed  CAS  Google Scholar 

  67. Grob P, Jilg W, Bornhak H, et al. Serological pattern “anti-HBc alone”: report on a workshop. J Med Virol. 2000;62:450–5.

    Article  PubMed  CAS  Google Scholar 

  68. De Feo TM, Poli F, Mozzi F, et al. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. Transplant Proc. 2005;37:1238–9.

    Article  PubMed  Google Scholar 

  69. Liaw YF, Sheen IS, Chen TJ, et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology. 1991;13:627–31.

    Article  PubMed  CAS  Google Scholar 

  70. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–2.

    Article  PubMed  Google Scholar 

  71. Lampertico P, Maini M, Papatheodoridis G. Optimal management of hepatitis B virus infection – EASL Special Conference. J Hepatol. 2015;63:1238–53.

    Article  PubMed  Google Scholar 

  72. Wong VW, Wong GL, Yiu KK, Chim AM, Chu SH, Chan H-Y, et al. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B. J Hepatol. 2011;54:236–42.

    Article  PubMed  CAS  Google Scholar 

  73. He B, Zhang Y, Lü M-H, Cao Y-L, Fan Y-H, Deng J-Q, et al. Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B: a meta-analysis. Eur J Gastroenterol Hepatol. 2013;25:926–34.

    Article  PubMed  CAS  Google Scholar 

  74. Ito K, Yotsuyanagi H, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.

    Article  PubMed  CAS  Google Scholar 

  75. Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med. 1989;87(3A):14S–20S.

    Article  PubMed  CAS  Google Scholar 

  76. World Health Organization. Hepatitis B vaccines: WHO position paper. Weekly Epidemiological Record. 2009;40(84):405–20.

    Google Scholar 

  77. Hoover KW, Butler M, Workowski KA, et al. Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis. 2012;39(5):349–53.

    Article  PubMed  CAS  Google Scholar 

  78. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health. 2001;91(6):965–71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  79. WHO Hepatitis C Fact Sheet. Available at http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed 15 February 2018.

  80. Afdhl NH. The natural history of hepatitis C. Semin Liver Dis. 2004;24:3–8.

    Article  Google Scholar 

  81. Grebely J, Petoumenos K, Hellard M, et al. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology. 2010;52:1216–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  82. Thomson EC, Nastououli E, Main J, et al. Delayed anti-HCV antibody response in HIV positive men acutely infected with HCV. AIDS. 2009;23:89–93.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Jones L, Uriel A, Kaplan D, et al. Natural history and treatment outcome of acute hepatitis C with and without HIV co-infection in a North American cohort. In: 59th Annual Meeting of the American Association for the Study of Liver Disease (AASLD) 2008; October 31–November 04, San Francisco, CA, USA; abstract 1838.

    Google Scholar 

  84. Thomson EC, Fleming VM, Main J, et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1 infected men. Gut. 2011;60:837–45.

    Article  PubMed  Google Scholar 

  85. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450–6.

    Article  PubMed  CAS  Google Scholar 

  86. Paul D, Bartenschlager R. Architecture and biogenesis of plus-strand RNA virus replication factories. World J Virol. 2013;2:32–48.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Romero-Brey I, Merz A, Chiramel A, et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog. 2012;8:e1003056.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59:318–27.

    Article  PubMed  Google Scholar 

  89. Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87.

    Article  PubMed  Google Scholar 

  90. Welzel T, Bhardwaj N, Hedskog C, et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol. 2017;67:224–36.

    Article  PubMed  Google Scholar 

  91. Guerra J, Garenne M, Mohamed MK, et al. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat. 2012;19:560–7.

    Article  PubMed  CAS  Google Scholar 

  92. Chak E, Talal AH, Sherman KE, et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011;31:1090–101.

    Article  PubMed  Google Scholar 

  93. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1–32.

    PubMed  Google Scholar 

  94. Williams IT, Bell BP, Kuhnert W, et al. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med. 2011;171:242–8.

    Article  PubMed  Google Scholar 

  95. Centers for Disease Control and Prevention. Surveillance for viral hepatitis – United States, 2015. Available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm#tabs-6-4. Accessed on 15 February 2018.

  96. Lvov DK, Samokhvalov EI, Tsuda F, et al. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. Arch Virol. 1996;141:1613–22.

    Article  PubMed  CAS  Google Scholar 

  97. Mühlberger N, Schwarzer R, Lettmeier B, et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009;9:34.

    Article  PubMed  PubMed Central  Google Scholar 

  98. European Center for Disease Control and Prevention. Hepatitis C – Annual epidemiological report for 2015. Available at https://ecdc.europa.eu/en/publications-data/hepatitis-c-annual-epidemiological-report-2015. Accessed 15 February 2018.

  99. Tahan V, Karaca C, Yildirim B, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol. 2005;100:821–4.

    Article  PubMed  Google Scholar 

  100. Marincovich B, Castilla J, del Romero J, et al. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect. 2003;79:160–2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol. 2004;99:855–9.

    Article  PubMed  Google Scholar 

  102. Kao JH, Liu CJ, Chen PJ, et al. Low incidence of hepatitis C virus transmission between spouses: a prospective study. J Gastroenterol Hepatol. 2000;15:391–5.

    Article  PubMed  CAS  Google Scholar 

  103. Frederick T, Burian P, Terrault N, et al. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women’s Interagency HIV Study (WIHS). AIDS Patient Care STDs. 2009;23:915–23.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore–an analysis of 309 sex partnerships. J Infect Dis. 1995;171:768–75.

    Article  PubMed  CAS  Google Scholar 

  105. Wang CC, Krantz E, Klarquist J, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis. 2007;196:1474–82.

    Article  PubMed  Google Scholar 

  106. Sun HY, Chang SY, Yang ZY, et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012;50:781–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Russell M, Chen MJ, Nochajski TH, et al. Risky sexual behavior, bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a sexually transmitted disease clinic. Am J Public Health. 2009;99:S173–9.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Browne R, Asboe D, Gilleece Y, et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men: is sexual transmission feeding the increase? Sex Transm Infect. 2004;80:326–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  109. Puoti M, Lorenzini P, Girardi E, et al. Incidence and progression to cirrhosis of HCV superinfection in persons living with HIV (PLHIV). In: 20th Conference on Retroviruses and Opportunistic Infections (CROI), 03–06 March 2013, Atlanta, GA, USA; abstract 638.

    Google Scholar 

  110. Katayama K, Kumagai J, Komiya Y, et al. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology. 2004;47:57–64.

    Article  PubMed  CAS  Google Scholar 

  111. Van de Laar TJW, Matthews GV, Prins M, et al. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS. 2010;24:1799–812.

    Article  PubMed  Google Scholar 

  112. Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS. 2006;21:983–91.

    Article  Google Scholar 

  113. Gotz HM, van Doornum G, Niesters HG, et al. A cluster of acute hepatitis C virus infection among men who have sex with men: results from contact tracing and public health implication. AIDS. 2005;19:969–74.

    Article  PubMed  Google Scholar 

  114. Van de Laar TJW, Van der Bij AK, Prins M, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007;196:230–8.

    Article  PubMed  Google Scholar 

  115. Rauch A, Rickenbach M, Weber R, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort study. Clin Infect Dis. 2005;41:395–402.

    Article  PubMed  Google Scholar 

  116. Giraudon I, Ruf M, Maguire H, et al. Increase in newly acquired hepatitis C in HIV positive men who have sex with men across London and Brighton, 2002-2006. Is this an outbreak? Sex Transm Infect. 2008;84:111–5.

    Article  PubMed  CAS  Google Scholar 

  117. Urbanus AT, van de Laar TJW, Stolte JG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23:F1–7.

    Article  PubMed  Google Scholar 

  118. McFaul K, Maghlaoui A, Nzuruba M, et al. Acute hepatitis C infection in HIV-negative men who have sex with men. J Viral Hepat. 2014;22:535–8.

    Article  PubMed  Google Scholar 

  119. Nelson M. 10th Co-infection Workshop, 12–13 June 2014, Paris, France.

    Google Scholar 

  120. Hoorneborg E, Achtenbergh RCA, Schim van der Loeff MF, et al. MSM starting preexposure prophylaxis are at risk of hepatitis C infection. AIDS. 2017;31:1603–10.

    Article  Google Scholar 

  121. Charre C, Cotte L, Kramer R, et al. Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men. PLoS One. 2018;13:e0190340.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  122. Lambers FA, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS. 2011;25:F21–7.

    Article  PubMed  Google Scholar 

  123. Ingiliz P, Krznaric I, Stellbrink HJ, et al. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med. 2014;15:355–61.

    Article  PubMed  CAS  Google Scholar 

  124. Martin TCS, Martin NK, Hickman M, et al. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS. 2013;27:2551–7.

    Article  PubMed  Google Scholar 

  125. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975–9.

    Article  PubMed  CAS  Google Scholar 

  126. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005;40:951–8.

    Article  PubMed  Google Scholar 

  127. Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS. 2009;23:89–93.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Vanhommering JW, Thomas XV, van del Meer JTM, et al. Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin Infect Dis. 2014;59:1678–85.

    Article  CAS  Google Scholar 

  129. Mosley JW, Operskalski EA, Tobler LH, et al. Viral and host factors in early hepatitis C virus infection. Hepatology. 2005;42:86–92.

    Article  PubMed  CAS  Google Scholar 

  130. Basu PP, Shah NJ, Aloysius MM, Brown R Jr. Sofosbuvir and ledipasvir vs sofosbuvir and simeprevir for acute hepatitis C: a RCT (SLAM C study). Hepatol Int. 2016;10:S14–5.

    Google Scholar 

  131. Rockstroh JK, Bhagani S, Hyland RH, et al. Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial. Lancet Gastroenterol Hepatol. 2017;2:347–53.

    Article  PubMed  Google Scholar 

  132. Deterding K, Spinner C, Schott E, et al. Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: the HEPNET acute HCV IV study. J Hepatol. 2016;64:S211.

    Article  Google Scholar 

  133. EASL recommendations on Treatment of Hepatitis C 2016. Available at http://www.easl.eu/medias/cpg/HCV2016/English-report.pdf. Accessed 15 February 2018.

  134. Recommendations for Testing, Managing, and Treating hepatitis C. Available at https://www.hcvguidelines.org/unique-populations/acute-infection. Accessed 15 February 2018.

Download references

Author information

Authors and Affiliations

  1. Niguarda Hepatitis Center, Department of Infectious Diseases, ASST Grande Ospedale Metropolitano “Niguarda”, Milan, Italy

    Roberto Rossotti & Massimo Puoti

Authors
  1. Roberto Rossotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Puoti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Puoti .

Editor information

Editors and Affiliations

  1. STI/HIV Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy

    Antonio Cristaudo

  2. STI/HIV Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy

    Massimo Giuliani

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rossotti, R., Puoti, M. (2020). Sexually Transmitted Hepatitis. In: Cristaudo, A., Giuliani, M. (eds) Sexually Transmitted Infections . Springer, Cham. https://doi.org/10.1007/978-3-030-02200-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02200-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02199-3

  • Online ISBN: 978-3-030-02200-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation